84 related articles for article (PubMed ID: 2611524)
1. Cortical muscarinic receptors in demented patients with Alzheimer's disease or Parkinson's disease.
Lange KW; Wells FR; Rossor MN; Jenner P; Marsden CD
Br J Pharmacol; 1989 Dec; 98 Suppl():817P. PubMed ID: 2611524
[No Abstract] [Full Text] [Related]
2. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y
Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706
[TBL] [Abstract][Full Text] [Related]
3. Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
Perry RH; Perry EK; Smith CJ; Xuereb JH; Irving D; Whitford CA; Candy JM; Cross AJ
J Neural Transm Suppl; 1987; 24():131-6. PubMed ID: 2824687
[TBL] [Abstract][Full Text] [Related]
4. Changes of muscarinic cholinergic binding by lymphocytes in Parkinson's disease with and without dementia.
Rabey JM; Grynberg E; Graff E
Ann Neurol; 1991 Dec; 30(6):847-50. PubMed ID: 1789698
[TBL] [Abstract][Full Text] [Related]
5. Deposition of Alzheimer's disease amyloid (A4) protein in the cerebral cortex in Parkinson's disease.
Mastaglia FL; Masters CL; Beyreuther K; Kakulas BA
Prog Clin Biol Res; 1989; 317():475-84. PubMed ID: 2690109
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes.
Beal MF; Clevens RA; Mazurek MF
Synapse; 1988; 2(4):463-7. PubMed ID: 2903567
[TBL] [Abstract][Full Text] [Related]
7. Neurochemistry of dementia.
Whitehouse PJ; Unnerstall JR
Eur Neurol; 1988; 28 Suppl 1():36-41. PubMed ID: 2967756
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease.
Quirion R; Aubert I; Lapchak PA; Schaum RP; Teolis S; Gauthier S; Araujo DM
Trends Pharmacol Sci; 1989 Dec; Suppl():80-4. PubMed ID: 2694529
[TBL] [Abstract][Full Text] [Related]
9. Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins.
Vermersch P; Delacourte A; Javoy-Agid F; Hauw JJ; Agid Y
Ann Neurol; 1993 May; 33(5):445-50. PubMed ID: 8498822
[TBL] [Abstract][Full Text] [Related]
10. Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
Metter EJ; Riege WH; Kameyama M; Kuhl DE; Phelps ME
J Cereb Blood Flow Metab; 1984 Dec; 4(4):500-6. PubMed ID: 6238975
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Perry EK; Smith CJ; Court JA; Perry RH
J Neural Transm Park Dis Dement Sect; 1990; 2(3):149-58. PubMed ID: 2175197
[TBL] [Abstract][Full Text] [Related]
12. Cortical muscarinic receptor subtypes and Alzheimer's disease.
Caulfield MP; Straughan DW; Cross AJ; Crow T; Birdsall NJ
Lancet; 1982 Dec; 2(8310):1277. PubMed ID: 6128572
[No Abstract] [Full Text] [Related]
13. [Parkinson's disease and Alzheimer's disease--similarities in magnetic resonance imaging parameters and their possible explanation].
Ebmeier KP; Besson JA; Cherryman G; Smith F
Z Gerontol; 1988; 21(3):142-5. PubMed ID: 3407284
[TBL] [Abstract][Full Text] [Related]
14. A subcortico-cortical cholinergic system is affected in Parkinson's disease.
Dubois B; Ruberg M; Javoy-Agid F; Ploska A; Agid Y
Brain Res; 1983 Dec; 288(1-2):213-8. PubMed ID: 6661617
[TBL] [Abstract][Full Text] [Related]
15. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic acetylcholine receptors as CNS drug targets.
Langmead CJ; Watson J; Reavill C
Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
[TBL] [Abstract][Full Text] [Related]
17. Is "subcortical dementia" a recognizable clinical entity?
Mayeux R; Stern Y; Rosen J; Benson F
Ann Neurol; 1983 Sep; 14(3):278-83. PubMed ID: 6227275
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptides in neurological disease.
Beal MF; Martin JB
Ann Neurol; 1986 Nov; 20(5):547-65. PubMed ID: 2947536
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
Whitehouse PJ; Kellar KJ
J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
[TBL] [Abstract][Full Text] [Related]
20. Aminergic systems in Alzheimer's disease and Parkinson's disease.
D'Amato RJ; Zweig RM; Whitehouse PJ; Wenk GL; Singer HS; Mayeux R; Price DL; Snyder SH
Ann Neurol; 1987 Aug; 22(2):229-36. PubMed ID: 3477996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
